Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's health and wellness company. It is focused on the commercialization of a revolutionary, non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The Viveve System incorporates clinically-proven, cryogen-cooled, monopolar radiofrequency (CMRF) energy to uniformly deliver deep- penetrating volumetric heat while gently cooling surface tissue to treat the condition of vaginal laxity.
Type
Public
HQ
Sunnyvale, US
Founded
2005
Size (employees)
42 (est)
Website
viveve.com
Viveve was founded in 2005 and is headquartered in Sunnyvale, US
Report incorrect company information

Viveve Office Locations

Viveve has an office in Sunnyvale
Sunnyvale, US (HQ)
150 Commercial St
Show all (1)
Report incorrect company information

Viveve Financials and Metrics

Viveve Financials

Viveve's revenue was reported to be $15.29 m in FY, 2017
USD

Revenue (Q1, 2018)

3.7 m

Gross profit (Q1, 2018)

1.3 m

Gross profit margin (Q1, 2018), %

36.4%

EBIT (Q1, 2018)

(11.3 m)

Market capitalization (25-May-2018)

76 m

Closing share price (25-May-2018)

2.4

Cash (31-Mar-2018)

38.4 m
Viveve's current market capitalization is $76 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.3 m90 k1.4 m7.1 m15.3 m

Revenue growth, %

(93%)1508%394%

Cost of goods sold

531 k50 k985 k4.6 m7.8 m

Gross profit

743 k40 k462 k2.5 m7.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

348 k54 k73 k17.2 k38 k73 k584 k1.3 m1.6 m1.8 m3 m3.1 m3.7 m

Cost of goods sold

124 k31 k24 k14.7 k50 k53 k417 k936 k1 m1.2 m1.6 m1.8 m2.4 m

Gross profit

224 k23 k49 k2.5 k(12 k)20 k167 k348 k534 k691 k1.4 m1.2 m1.3 m

Gross profit Margin, %

64%43%67%14%(32%)27%29%27%34%37%47%40%36%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

769 k895 k7.4 m8.1 m20.7 m

Accounts Receivable

6 k593 k2.1 m

Inventories

117 k923 k1.6 m2.7 m2.4 m

Current Assets

1.5 m2 m11.1 m13.9 m32.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

1.4 m128 k87 k2 m221 k8.4 m6.1 m5 m19.9 m14 m31.4 m31.1 m38.4 m

Accounts Receivable

3.8 k35 k6 k239 k791 k589 k1.8 m4 m3.8 m

Inventories

145 k112 k101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m2 m3.8 m

Current Assets

2.4 m576 k704 k2.3 m1.3 m10.4 m8.6 m8.3 m22.6 m18.5 m39 m38.8 m52.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.5 m(6.2 m)(12.4 m)(20.1 m)(37 m)

Depreciation and Amortization

53 k56 k77 k111 k449 k

Inventories

42 k(41 k)(879 k)(1.2 m)(67 k)

Accounts Payable

48 k(551 k)1 m1.7 m1.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(609 k)(2.4 m)2.3 m(2.5 m)(2.5 m)(3 m)(3.2 m)(12.7 m)

Depreciation and Amortization

150 k

Inventories

101 k136.9 k167 k337 k645 k926 k845 k1.4 m2.4 m(1.5 m)

Accounts Payable

775 k566.1 k612 k612 k1.1 m1.6 m1.9 m2.5 m3.4 m(934 k)
USDY, 2018

Financial Leverage

3 x
Show all financial metrics
Report incorrect company information

Viveve News and Updates

Middle East and North Africa (MENA) Medical Aesthetic Devices Market is Expected to Represent US$755.8 mn by 2024

Middle East and North Africa (MENA) Medical Aesthetic Devices Market: Increasing Aesthetic Consciousness among Consumers to Boost Growth, says TMR Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information